The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Chemicals And Chemical Products 20 - Manufacture of chemicals and chemical products
300 jobs Number of planned job creations
Announcement Date
24 January 2006
Employment effect (start)
Foreseen end date
Description
US biotech company Amgen said it was building a European development centre at Uxbridge, Middlesex, as well as expanding its facility in Cambridge, creating 300 jobs. Amgen's expansion would almost double its research and development capacity in the UK. 'The decision confirms the UK as a major worldwide scientific hub for Amgen,' said Jeremy Haigh, the company's head of research and development in Europe. The UK initiative is part of a wider programme in Europe and the US, including a $1 billion investment in Ireland, which will create more than 1,000 jobs.
Sources
25 February 2006: The Guardian
Citation
Eurofound (2006), Amgen, Business expansion in United Kingdom, factsheet number 62821, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/62821.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
